Management and Board Members

Dr. Amnon Gonenne, President & CEO
Dr. Amnon Gonenne holds a doctorate degree in Biochemistry and Biophysics from Syracuse University, New York and completed his post-doctoral training at the University of California San Diego, School of Medicine. Dr. Gonenne has more than 20 years experience in the biotechnology field in the US and has held a number of top executive positions in regulatory affairs, supervision of international clinical trials, VP of Corporate Development (BioTechnology General Corp., NY) and CEO (Immunotherapy Inc., NY). He has led the successful registration and licensing of several genetically engineered products in the US. Between the years 2000-2002 he served as CEO of a VC fund (Elscint Biomedical Investment, Israel) which has made major investments in Gamida Cell Ltd. (Israel), a leading world class stem cell company.

Dr. Eli Orr, Executive Vice President and Chief Scientific Officer
Dr. Orr is the developer of the MabCure technology and novel Mabs. Dr. Orr has been serving as a senior research scientist at the University of Leicester, Department of Genetics, for the past 30 years. He has received awards from several institutions, including a Wellcome Trust Personal Chair award for five years (1987), a Royal Society (UK) award for a visiting Professorship in Israel (1994) and an EU award for a visiting Professorship in Israel (1998).

Among his scientific accomplishments is the discovery, characterization and cloning of a number of proteins and genes (e.g. bacterial DNA gyrase, yeast non-muscle heavy chain myosin and bacterial genes involved in the production of antibiotics).

Itshak Zivan, Director
Mr. Zivan is the founder of Zivtex Ltd. (UK), and served as its chief executive officer and a director from 1992 to 2007. He is a graduate of the Israel Institute of Technology (Technion) in computer science and engineering and has more than 20 years experience in business development and management. He also served as deputy managing director of Pex Ltd. (UK) and as managing director and a member of the board of Delta Textiles (Israel).

The products represented as in development and found in the product pipeline are intended for investors and members of the media to provide general information on MabCure. This information is not represented to be a complete description and is subject to change without notice. MabCure may from time to time update this information but does not warrant that will take place at any particular time nor assume any obligation to update this information.